Chromoendoscopy is a valuable tool for screening of high-risk patients with head and neck cancer for early detection of esophageal cancer

Digestion

Volumn 73, Issue 2-3, 2006, Pages 160-166

  Möschler, Oliver ^a   Spahn, Thomas Werner ^a   Middelberg Bisping, Christina ^a   Grosse Thie, Wolfram ^a   Christoph, Bernd ^a   Kloeppel, Günter ^b   Mueller, Michael Karl ^a  

^a MarienHospital Osnabruck   (Germany)

^b UNIVERSITY OF KIEL   (Germany)

Author keywords

Carcinoma in situ; Endoscopy; Esophageal cancer; Head and neck cancer

Indexed keywords

ADULT; AGED; ALCOHOL ABUSE; ARTICLE; BARRETT ESOPHAGUS; CANCER ADJUVANT THERAPY; CANCER DIAGNOSIS; CANCER PALLIATIVE THERAPY; CANCER RISK; CANCER SCREENING; CANCER SURGERY; CARCINOMA IN SITU; CHROMOENDOSCOPY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; EARLY DIAGNOSIS; ESOPHAGITIS; ESOPHAGOGASTRODUODENOSCOPY; ESOPHAGUS BIOPSY; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SMOKING; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

EID: 33746653028     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000094523     Document Type: Article

References (20)

1. Gao X, Fisher SG, Mohideen N, Emami B: Second primary cancers in patients with laryngeal cancer: a population-based study. Int J Radiat Oncol Biol Phys 2003;56:427-435.
2. Brown LM, Devesa SS: Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002;11:235-256.
3. Bareiss D, Stabenow R, Müller R: Aktuelle Epidemiologie des Ösophaguskarzinoms in Deutschland. Dtsch Med Wochenschr 2002; 127:1367-1374.
4. Weir HK, Thun MJ, Hankey BF, Ries LA, Howe HL, Wingo PA, et al: Annual report to the nation on the status of cancer, 1975-2000, featuring the uses of surveillance data for cancer prevention and control. J Natl Cancer Inst 2003;95:1276-1299.
5. Schiller W: Early diagnosis of carcinoma of the cervix. Surg Gynecol Obstet 1933;56:210-222.
6. Dawsey SM, Fleischer DE, Wang GQ, Zhou B, Kidwell JA, Lu N, et al: Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian, China. Cancer 1998;83:220-231.
7. Ban S, Toyonaga A, Harada H, Ikejiri N, Tanikawa K: Iodine staining for early endoscopic detection of esophageal cancer in alcoholics. Endoscopy 1998;30:253-257.
8. Fagundes RB, de Barros SG, Putten AC, Mello ES, Wagner M, Bassi LA, et al: Occult dysplasia is disclosed by Lugol chromoendoscopy in alcoholics at high risk for squamous cell carcinoma of the esophagus. Endoscopy 1999;31:281-285.
9. Doberauer C, Henning B, Sanner B: Früherkennung von Ösophaguskarzinomen mittels Chromoendoskopie bei Patienten mit chronischer Alkoholkrankheit. Stuttgart, Thieme, 1999.
10. Yokoyama A, Ohmori T, Makuuchi H, Maruyama K, Okuyama K, Takahashi H, et al: Successful screening for early esophageal cancer in alcoholics using endoscopy and mucosa iodine staining. Cancer 1995;76:928-934.
11. Meyer V, Burtin P, Bour B, Blanchi A, Cales P, Oberti F, et al: Endoscopic detection of early esophageal cancer in a high-risk population: does Lugol staining improve videoendoscopy? Gastrointest Endosc 1997;45:480-484.
12. Shiozaki H, Tahara H, Kobayashi K, Yano H, Tamura S, Imamoto H, et al: Endoscopic screening of early esophageal cancer with the Lugol dye method in patients with head and neck cancers. Cancer 1990;66:2068-2071.
13. Ina H, Shibuya H, Ohashi I, Kitagawa M: The frequency of a concomitant early esophageal cancer in male patients with oral and oropharyngeal cancer: screening results using Lugol dye endoscopy. Cancer 1994;73:2038-2041.
14. Fukuzawa K, Noguchi Y, Yoshikawa T, Saito A, Doi C, Makino T, et al: High incidence of synchronous cancer of the oral cavity and the upper gastrointestinal tract. Cancer Lett 1999;144:145-151.
15. Tincani AJ, Brandalise N, Altemani A, Scanavini RC, Valerio JB, Lage HT, et al: Diagnosis of superficial esophageal cancer and dysplasia using endoscopic screening with a 2% Lugol dye solution in patients with head and neck cancer. Head Neck 2000;22:170-174.
16. Scherübl H, von Lampe B, Faiss S, Daubler P, Bohlmann P, Plath T, et al: Screening for esophageal neoplasia in patients with head and neck cancer. Br J Cancer 2002;86:239-243.
17. Roullet MH, Wind P, Zinzindohoue F, Laccourreye O, Berger A, Chevallier JM, et al: Esophagectomy for squamous cell carcinoma of the esophagus isolated or associated with head and neck cancer: long-term survival. Ann Chir 2001;126:526-534.
18. Kohmura T, Hasegawa Y, Matsuura H, Terada A, Takahashi M, Nakashima T: Clinical analysis of multiple primary malignancies of the hypopharynx and esophagus. Am J Otolaryngol 2001;22:107-110.
19. Wind P, Roullet MH, Douard R, Laccoureye O, Brasnu D, Cugnenc PH: Experience in the treatment of synchronous and metachronous carcinoma of the esophagus and the head and neck. J Surg Oncol 2000;73:138-142.
20. Wind P, Roullet MH, Quinaux D, Laccoureye O, Brasnu D, Cugnenc PH: Long-term results after esophagectomy for squamous cell carcinoma of the esophagus associated with head and neck cancer. Am J Surg 1999;178:251-255.